0001104659-16-121557.txt : 20160517 0001104659-16-121557.hdr.sgml : 20160517 20160517113101 ACCESSION NUMBER: 0001104659-16-121557 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160516 FILED AS OF DATE: 20160517 DATE AS OF CHANGE: 20160517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Shawn CENTRAL INDEX KEY: 0001674756 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 161656536 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 a4.xml 4 X0306 4 2016-05-16 0 0001492674 T2 Biosystems, Inc. TTOO 0001674756 Lynch Shawn 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 8.88 2016-05-16 4 A 0 146600 0 A 2026-05-16 Common Stock 146600 146600 D 25% of the total shares vest on 05/16/2017, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 05/16/2020. /s/ Chris Martin, Attorney-in-fact 2016-05-17